Hardman Johnston Global Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hardman Johnston Global Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,160	Closed	-$2.56M	–	82
2020 Q4	$2.56M	Sell	22,160 -46,820	-68%	-$5.25M	0.07%	54
2020 Q3	$6.71M	Buy	68,980 +6,960	+11%	+$801K	0.25%	49
2020 Q2	$7.61M	Buy	62,020 +8,290	+15%	+$941K	0.34%	48
2020 Q1	$4.71M	Sell	53,730 -9,180	-15%	-$972K	0.27%	46
2019 Q4	$6.58M	Buy	62,910 +3,860	+7%	+$433K	0.27%	47
2019 Q3	$6.79M	Buy	59,050 +3,990	+7%	+$606K	0.31%	44
2019 Q2	$9.49M	Buy	55,060 +17,810	+48%	+$3.08M	0.42%	43
2019 Q1	$6.28M	Buy	37,250 +6,280	+20%	+$935K	0.28%	47
2018 Q4	$3.02M	Sell	30,970 -3,520	-10%	-$462K	0.16%	48
2018 Q3	$5.96M	Buy	34,490 +11,320	+49%	+$1.63M	0.26%	45
2018 Q2	$3.23M	Buy	+23,170	New	+$3.29M	0.14%	47

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hardman Johnston Global Advisors's GWPH Position: Q1 2021 in Review

Hardman Johnston Global Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 22,160 shares — an estimated $2.56M sold.

Hardman Johnston Global Advisors first reported a position in GWPH in Q2 2018 and held it in 11 quarters. The position peaked at $9.49M in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Hardman Johnston Global Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Hardman Johnston Global Advisors sold 22,160 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $2.56M.
Hardman Johnston Global Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 11 quarters.
Hardman Johnston Global Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.49M in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Hardman Johnston Global Advisors's 13F filing for Q1 2021, filed 12 May 2021.